Koshiro Fukuda
Hongo, 1138655, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Clinical Utility and Optimal Sampling Timing of Urinary Trypsinogen-2 for Early Prediction of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Observational Study.
Journal: Digestive diseases and sciences
Published: May 01, 2026
Herbal and pharmacological treatments in cancer-related fatigue.
Journal: Translational gastroenterology and hepatology
Published: March 08, 2026
Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 24, 2026
Adipose tissue and survival among patients with advanced biliary tract cancer.
Journal: Japanese journal of clinical oncology
Published: December 25, 2025
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: November 08, 2025
Chemotherapeutic Strategy for Metastatic or Recurrent Appendiceal Adenocarcinoma
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 21, 2025
Effect of pretreatment vascular endothelial growth factor inhibitor use on the safety and efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
Journal: International journal of clinical oncology
Published: February 12, 2025
Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings.
Journal: Therapeutic advances in gastroenterology
Published: December 15, 2024
Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT database.
Journal: Journal of gastroenterology
Published: December 02, 2024
Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency.
Journal: Clinical journal of gastroenterology
Published: November 23, 2024
Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with a Poor Performance Status.
Journal: Internal medicine (Tokyo, Japan)
Published: June 19, 2024
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database.
Journal: Journal of gastroenterology
Published: May 26, 2024
Last Updated: 09/26/2026